Trials / Conditions / Childhood Acute Myeloblastic Leukemia With Maturation (M2)

Childhood Acute Myeloblastic Leukemia With Maturation (M2)

10 registered clinical trials studyying Childhood Acute Myeloblastic Leukemia With Maturation (M2).

Status	Trial	Sponsor	Phase
Terminated	Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia NCT01801046	University of Southern California	Phase 1
Completed	Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia NCT01076569	Children's Oncology Group	—
Completed	Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia NCT01146210	Children's Oncology Group	—
Completed	Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary NCT00666588	National Cancer Institute (NCI)	Phase 2
Completed	Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysp NCT00369317	Children's Oncology Group	Phase 3
Terminated	Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid NCT00096148	National Cancer Institute (NCI)	Phase 2
Terminated	Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leuk NCT00042796	National Cancer Institute (NCI)	Phase 1
Completed	Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 i NCT00006363	National Cancer Institute (NCI)	Phase 3
Completed	Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogeno NCT00002798	National Cancer Institute (NCI)	Phase 3
Completed	High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patient NCT01177371	Case Comprehensive Cancer Center	Phase 2